GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
40.00
+1.06 (2.72%)
May 14, 2026, 11:12 AM EDT - Market open
GeneDx Holdings Employees
GeneDx Holdings had 1,300 employees as of December 31, 2025. The number of employees increased by 300 or 30.00% compared to the previous year.
Employees
1,300
Change (1Y)
300
Growth (1Y)
30.00%
Revenue / Employee
$340,522
Profits / Employee
-$59,852
Market Cap
1.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,300 | 300 | 30.00% |
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Mar 31, 2021 | 985 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Twist Bioscience | 979 |
| GRAIL | 910 |
| Castle Biosciences | 883 |
| CareDx | 765 |
WGS News
- 2 days ago - Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud - GlobeNewsWire
- 9 days ago - GeneDx price target lowered to $85 from $153 at Craig-Hallum - TheFly
- 9 days ago - GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 9 days ago - GeneDx price target lowered to $55 from $60 at TD Cowen - TheFly
- 9 days ago - GeneDx price target lowered to $90 from $170 at BTIG, removed from Top Picks - TheFly
- 9 days ago - GeneDx price target lowered to $70 from $100 at Guggenheim - TheFly
- 9 days ago - GeneDx price target lowered to $75 from $155 at Wells Fargo - TheFly
- 9 days ago - GeneDx reports Q1 adjusted loss ($8.2M) vs. ($9.2M) last year - TheFly